Form 4: Soligenix CEO Acquires 45,000 Stock Options
SEC Form 4 Filing
Soligenix CEO Christopher J. Schaber acquired 45,000 stock options on December 12, 2024, which vest over a three-year period.
Summary
- Christopher J. Schaber, the Chairman, CEO, and President of Soligenix, Inc., acquired 45,000 stock options on December 12, 2024.
- The options have an exercise price of $3.31 per share.
- 25% of the options vested immediately, with the remaining 75% vesting in 12 equal installments every three months starting from December 12, 2024.
- The options expire on December 11, 2034.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management with shareholder interests. There are no negative implications.
Positives
- The acquisition of stock options by the CEO could be seen as a positive sign of confidence in the company's future performance.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a standard practice for executive compensation in the biotech industry.
- The vesting schedule of 25% immediately and the remainder over three years is a fairly typical vesting schedule for stock options.
Stakeholder Impact
- The stock option grant could positively impact shareholder confidence by aligning management's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 12/12/2024 | Date of stock option acquisition and initial vesting. |
| 12/11/2034 | Expiration date of the stock options. |
Keywords
stock options, insider trading, executive compensation, Soligenix, SNGX, Christopher J. Schaber
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.